SCHEMBL25519645

SCHEMBL25519645

Cc1ccnc2c(C(C)C)ccnc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.46
CCR5 P51681 2/20 0.46
CCR8 P51685 2/20 0.46
PSMD14 O00487 1/20 0.41
COPS5 Q92905 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.36
LMNA P02545 2/20 0.36
NOS3 P29474 3/20 0.35
NOS2 P35228 3/20 0.35
HTR1A P08908 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPC1 O15118 1/20 0.31
HSP90AA1 P07900 1/20 0.31
AURKA O14965 1/20 0.30
DAPK3 O43293 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13193188 0.87 CCR1 (0.37) CCR1CCR5CCR8PSMD14COPS5
SCHEMBL12203219 0.81 CCR1 (0.65) CCR1CCR5CCR8PSMD14COPS5
SCHEMBL12032781 0.79 SLC40A1 (0.37) CCR1CCR5CCR8PSMD14COPS5
SCHEMBL12131703 0.76 HTR1A (0.53) CCR1CCR5CCR8PSMD14COPS5
SCHEMBL12533426 0.76 PSMD14 (0.62) CCR1CCR5CCR8PSMD14COPS5
SCHEMBL13394546 0.76 CCR1 (0.33) CCR1CCR5CCR8PSMD14COPS5
SCHEMBL26400675 0.74 HTR1A (0.39) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL12992620 0.74 CCR1 (0.38) CCR1CCR5CCR8PSMD14COPS5
SCHEMBL12992615 0.74 CCR1 (0.38) CCR1CCR5CCR8PSMD14COPS5
SCHEMBL23132774 0.71 PDPK1 (0.41) CCR1CCR5CCR8PSMD14COPS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 WO disclosed